melior discovery

About Us
Our Pipeline
Our Platform
Partnering with Us
Contact Us

Click here for the MLR-1023 non-confidential brochure          

melior melior discovery

Melior Pharmaceuticals about us

Many blockbuster drugs were only serendipitously discovered to be efficacious in the indications for which they were ultimately marketed. For example, Viagra® ($2 billion annual sales), Gemzar® ($1.2 billion annual sales), Evista® ($1.0 billion annual sales) and Propecia® are all examples of drugs that were originally developed for use in one indication but, by chance, were discovered to be effective for a very different one.

Melior Pharmaceuticals applies its unique theraTRACE® indications discovery platform to identify and develop new uses for small molecule therapeutics. This efficient and systematic platform has allowed Melior to rapidly evaluate a series of compounds and move them rapidly into clinical development. The company currently has three active, internal drug programs that demonstrate the utility of the platform to address major unmet medical needs.